Saturday 23.10.2010

Workshop Patiententag Scientific Session Satellite Symposium Main Program
Session details 14:00–17:30
Workshop 1

Social Medical Implication of Chronic Fatigue in HL

Room:Pfau (Dorint Hotel)
Session details 14:00–15:30
Workshop 1 (Parallel Sessions)

HL in Adolescents: a Controversy?

Room:Severin (Dorint Hotel)
Session details 14:00–15:30
Workshop 2 (Parallel Sessions)

Interim PET in HL

Room:Pipin II (Dorint Hotel)
  • 14:00

    Towards Standardization of Scanning and Reporting of Results

  • Logistics of the Network of Imaging Exchange and the Review Panel

  • Interim PET and the Role of Radiotherapy in Early Stage Disease

  • Interim-PET in Tailoring Therapy in Early Stage HL – The EORTC-GELA-IIL Experience

  • Interim-PET in the Therapeutic Strategy of Advanced Stage HL

  • Interim-PET in Patients with Advanced HL Treated with Non-ABVD Regimens

  • Interim-PET During BEACOPP Chemotherapy: Experience of the GHSG

Session details 14:00–15:30
Workshop 3 (Parallel Sessions)

Basic Research

Room:Pipin I (Dorint Hotel)
  • 14:00

    Molecular Cytogenetic Studies in Hodgkin Lymphoma

  • The role of KLF4 and FoxO1 in Hodgkin Lymphoma

  • JAK2 Rearrangements, Including the Novel SEC31A-JAK2 Fusion, Are Recurrent in Classical Hodgkin Lymphoma

  • HLA Expression and Genetic Associations in EBV Positive and EBV Negative Classical Hodgkin Lymphoma

  • Immune Escape in Hodgkin Lymphoma and PTLD – the Role and Targeting of Galectin-1

Session details 14:00–15:30
Workshop 4 (Parallel Sessions)

Follow-Up in Long Term Survivors: Recommendations

Room:Martin & Augustin (Dorint Hotel)
Session details 16:00–17:30
Workshop 6 (Parallel Sessions)

HL Pathologists’ Meeting

Room:Sandkaul (Dorint Hotel)
  • 16:00

    Methylation Pro ling of Mediastinal Gray Zone Lymphoma

  • DNA Methylation Analyses in Hodgkin Lymphoma

  • Mechanisms of Aberrant GATA-3 Expression in Classical Hodgkin Lymphoma

  • Genome-Wide Copy Number Analysis of Microdissected HRS Cells in Classical Hodgkin Lymphoma

Session details 16:00–17:30
Workshop 7 (Parallel Sessions)

NLPHL: Treatment Recommendations

Room:Martin & Augustin (Dorint Hotel)
Session details 16:00–17:30
Workshop 8 (Parallel Sessions)

Defining RT Field and Dose

Room:Pipin I (Dorint Hotel)
  • 16:00

    Evidence for Radiotherapy in Early Stage Hodgkin Lymphoma, Volume and Dose – Review of the Meta-Analyses

  • Evidence for Radiotherapy in Advanced Stage Hodgkin Lymphoma, Volume and Dose

  • RT Dose in Early Stages – the GHSG Studies

  • Reductions in Irradiated Volume in Hodgkin Lymphoma, IFRT and INRT

  • Is INRT Suitable for Pediatric Patients?

  • Highly Conformal Radiotherapy for Hodgkin Lymphoma, IMRT, Arc Therapy, Proton Therapy

  • Imaging for Highly Conformal Radiotherapy for Hodgkin Lymphoma

  • Uncertainties in Highly Conformal Radiotherapy for Hodgkin Lymphoma

  • Panel Discussion and Proposal for an ‘International Forum for Lymphoma Radiation Oncologists’

Session details 16:00–17:30
Workshop 9 (Parallel Sessions)

HL in Non-Western Countries

Room:Severin (Dorint Hotel)
  • 16:00

    Hodgkin Lymphoma in Non-Western Countries: Pathology

  • Hodgkin Lymphoma in Non-Western Countries: Africa

  • Hodgkin Lymphoma in Non-Western Countries: South America

  • Hodgkin Lymphoma in Non-Western Countries: Middle East

  • Hodgkin Lymphoma in Non-Western Countries: China

Session details 16:00–17:30
Workshop 10 (Parallel Sessions)

Lymphoma Response Evaluation

Room:Pipin II (Dorint Hotel)
  • 16:00

    Response Assessment in Clinical Practice and Clinical Research

  • Experience with PET in Hodgkin Lymphoma

  • Current Risk Adapted Clinical Trials in Hodgkin Lymphoma

  • Recent Modi cations of the International Response Criteria for Lymphoma

  • New Directions in Imaging for Lymphoma

Sunday 24.10.2010

Workshop Patiententag Scientific Session Satellite Symposium Main Program
Session details 09:00–12:15
Patiententag

An Interactive Survivor Symposium with Focus on Quality of Life

Room:Kleiner Saal
Session details 09:30–10:30
Scientific Session 1

The HL Stem Cell

Room:Großer Saal
  • 09:30

    Leukaemic Stem Cells: AML Show the Way

  • Cancer Stem Cells in Hodgkin Lymphoma

  • Aspects of the Relationship of Hodgkin and Reed/Sternberg Cells and Potential Precursor Cells

Session details 10:30–12:00
Scientific Session 2

Lymphoma Microenvironment

Room:Großer Saal
  • 10:30

    Classical Hodgkin Lymphoma Micro- environment. Pathologic Aspects and the Role of CD40 / CD40L

  • Gene and Micro-RNAs Signatures as Predictors of Risk in Hodgkin Lymphoma: Integrating Tumor and Microenvironment

  • Can Immunohistochemical Markers at Diagnosis Have the Same Predictive Value of Early Interim-PET in Classical Hodgkin Lymphoma?

  • Integrative Analysis Reveals Selective 9p24.1 Ampli cation, Increased PD-L1 Ligand Expression and Further Induction via JAK2 in Nodular Sclerosing Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma

Session details 12:15–13:30
Satellite Symposium

Lenalidomide in Lymphoma – Latest Update on Clinical Data

Room:Großer Saal
  • 12:15

    Rational and Clinical Experiences with Lenalidomide in Hodgkin Lymphoma

  • Progress in CLL Treatment

  • Emerging Treatment Options for Mantle Cell Lymphoma

Session details 14:00–15:00
Satellite Symposium

CD30 as a Target for Hodgkin Lymphoma

Room:Großer Saal
Session details 16:00–17:30
Satellite Symposium

Novel Approaches in the Treatment of Hodgkin Lymphoma: Beyond Chemotherapy

Room:Großer Saal
Session details 18:00–20:00
Main Program

Opening Ceremony

Room:Großer Saal
  • 18:00

    Bonadonna Lecture: The Role of Viral Infections in Hodgkin Lymphoma

  • Awards Ceremony

Session details 20:00
Main Program

Get Together

Room:Weinkeller

Monday 25.10.2010

Workshop Patiententag Scientific Session Satellite Symposium Main Program
Session details 08:30–10:00
Scientific Session 3

Basic Research

Room:Großer Saal
  • 08:30

    Pathogenesis of HL

  • cHL and Microenvironment

  • Rationale for Non-Genotoxic Treatment

  • From High Dimensional Data to Disease Mechanisms – NOTCH Signaling in Hodgkin Lymphoma

  • The Role of miRNAs in Hodgkin Lymphoma

  • Methylation Pro ling of Mediastinal Gray Zone Lymphoma Reveals a Distinctive Signature with Elements Shared by Classical Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma

Session details 10:30–12:00
Scientific Session 4 (Parallel Sessions)

Early Stages

Room:Großer Saal
  • 10:30

    Actions Following the Interim Analysis of the EORTC/GELA/IIL Intergroup H10 Trial

  • Debate: Role of Radiotherapy in Early Favorable HL

  • State of the Art and Future Perspectives

  • Early FDG-PET Scan Con rms Its Prognostic Impact Also in Localized Stage, ABVD Treated Hodgkin Lymphoma Patients

  • Involved Node Radiotherapy Signi cantly Reduces Lung, Breast and Thyroid Dose in Patients with Limited Stage Hodgkin Lymphoma

Session details 10:30–12:00
Workshop 11 (Parallel Sessions)

Pediatric HL

Room:Kleiner Saal
Session details 12:00–14:00
Satellite Symposium

State-of-the-Art and Future Approaches

Room:Großer Saal
Session details 14:00–15:30
Scientific Session 5

Special Challenges in HL

Room:Großer Saal
  • 14:00

    WS Report on Non-Western Countries

  • WS Report on HL Treatment of Adolescents

  • WS Report on NLPHL

  • Hodgkin Lymphoma and HIV Infection (HD- HIV): Prognostic Factors in 596 Patients (Pts) within the European Group for the Study of HIV and Tumours

  • Feasibility and Ef cacy of ABVD in Elderly Hodgkin Lymphoma Patients: Analysis of Two Randomized Prospective Multicenter Trials of the German Hodgkin Study Group (HD10 and HD11)

  • Autologous Stem Cell Transplantation for Adolescents and Young Adults with Relapsed or Refractory Hodgkin Lymphoma

Session details 16:00–17:30
Scientific Session 6

Survivorship

Room:Großer Saal
  • 16:00

    WS Report on Follow-Up Recommendations

  • Long-Term Outcome of Children and Adolescents

  • Quality of Life in HL

  • A Comprehensive Prospective National Database to Enhance Breast Cancer (BC) Screening Services for Hodgkin Lymphoma (HL) Survivors Treated with Supradiaphragmatic Radiotherapy (SRT) in England

  • A Prospective Study of Breast Magnetic Resonance Imaging (MRI) and Mammographic Screening in Long-Term Female Hodgkin Lymphoma (HL) Survivors

  • Coronary Artery Disease in Patients Treated for Hodgkin Lymphoma: Preliminary Results Using Computed Angiography Tomography

Session details 18:00–19:00
Satellite Symposium

New Aspects of Lymphoma Therapy

Room:Großer Saal
  • 18:00

    Mantle Cell Lymphoma – Quo Vadis?

  • Follicular Lymphoma – Bortezomib in the Relapsed/Refractory Setting

Tuesday 26.10.2010

Workshop Patiententag Scientific Session Satellite Symposium Main Program
Session details 08:30–10:00
Scientific Session 7

Transplantation

Room:Großer Saal
  • 08:30

    Randomized Trials

  • Role of allo-TX

  • Double APBSCT

  • Long Term Outcome of High-Dose Salvage Therapy for Patients with Early Stage Hodgkin Lymphoma (HL) Who Failed Initial Treatment with Combined Modality Treatment or Chemotherapy Alone

  • Relapse of Hodgkin Lymphoma after Autologous Stem Cell Transplantation (ASCT): Identi cation of Prognostic Factors Predicting Outcome

  • Allogeneic Stem Cell Transplantation for Hodgkin Lymphoma: a Retrospective Analysis of Data from the German Stem cell Transplantation Registry (DRST)

Session details 10:30–12:00
Scientific Session 8

New drugs

Room:Großer Saal
  • 10:30

    SGN-35

  • LBH-589

  • Everolimus for Relapsed/Refractory HL

  • Lenalidomide

  • Extended Follow-Up of the Safety of 131I Radiolabelled Anti-CD25 Antibody, Basiliximab, in Patients with CD25-Positive, Refractory Hodgkin Lymphoma

  • Initial Results from the SAPHIRE Study: a Phase II Trial with the Novel Oral Histone Deacetylase (HDAC) Inhibitor Resminostat in Relapsed or Refractory Hodgkin Lymphoma Patients

Session details 12:00–13:15
Satellite Symposium

New Mobilisation Strategies in Autologous Stem Cell Transplantation

Room:Großer Saal
  • 12:00

    The Role and Challenges of Autologous Transplantation in Hodgkin Lymphoma

  • Optimizing Stem Cell Mobilization with Plerixafor in Hodgkin Lymphoma

Session details 13:15–14:00
Main Program

Posterwalk

Room:Kleiner Saal
Session details 14:00–15:30
Scientific Session 9

PET

Room:Großer Saal
  • 14:00

    PET for Lymphoma Staging

  • Interim PET

  • PET during Follow-Up

  • Contribution of PET/CT in the Design of the Involved Node Radiotherapy (INRT) Concept for Patients with Localized Hodgkin Lymphoma: Preliminary Results on 117 Patients entered in the H10 Trial

  • Early Interim FDG-PET during Intensi ed BEACOPP Therapy for Advanced-Stage Hodgkin Lymphoma Shows a Lower Positive Predictive Value than during ABVD

  • A Bone Marrow Biopsy is Not Necessary in the Staging of Hodgkin Lymphoma (HL) Patients in the FDG-PET Era

Session details 16:00–17:30
Scientific Session 10

Advanced Stage

Room:Großer Saal
  • 16:00

    Update on Stanford V

  • Debate: Kairos or Chronos? Early versus Late Intensi cation in Advanced HL

  • HD15-PET: Final Analysis

  • Intensi ed ABVD for Newly Diagnosed Patients with Advanced-Stage Classical Hodgkin Lymphoma

  • BEACOPP is Superior to ABVD in Patients with Advanced Hodgkin Lymphoma and High Tumor Burden

Session details 17:30–19:00
Main Program

Closing Remarks

Room:Großer Saal

Basement

Allocations

shift key

Hold SHIFT key while scrolling to zoom the map.

Hold ALT key while scrolling to rotate the map.

pinch-gesture

Use two fingers to zoom, move, or rotate the map.

Floor plan of Basement Wardrobe Go to Ground Floor Go to Ground Floor Weinkeller Basement

Ground Floor

Allocations

shift key

Hold SHIFT key while scrolling to zoom the map.

Hold ALT key while scrolling to rotate the map.

pinch-gesture

Use two fingers to zoom, move, or rotate the map.

Floor plan of Ground Floor Go to Basement Go to Basement Go to First Floor Go to First Floor Go to Ground Level Kleiner Saal Ground Floor

First Floor

Allocations

  • Room details Großer Saal

    Main Program, Satellite Symposia, Workshop

shift key

Hold SHIFT key while scrolling to zoom the map.

Hold ALT key while scrolling to rotate the map.

pinch-gesture

Use two fingers to zoom, move, or rotate the map.

Floor plan of First Floor Go to Ground Floor Go to Ground Floor Großer Saal First Floor

Dorint Hotel: Ground Level

Allocations

shift key

Hold SHIFT key while scrolling to zoom the map.

Hold ALT key while scrolling to rotate the map.

pinch-gesture

Use two fingers to zoom, move, or rotate the map.

Floor plan of Dorint Hotel: Ground Level Go to Ground Floor Go to Ground Floor Go to First Floor Pipin II Sandkaul Pipin I Pfau Dorint Hotel: Ground Level

Dorint Hotel: First Floor

Allocations

shift key

Hold SHIFT key while scrolling to zoom the map.

Hold ALT key while scrolling to rotate the map.

pinch-gesture

Use two fingers to zoom, move, or rotate the map.

Floor plan of Dorint Hotel: First Floor Go to Ground Level Martin & Augustin Severin Dorint Hotel: First Floor

Exhibition

shift key

Hold SHIFT key while scrolling to zoom the map.

Hold ALT key while scrolling to rotate the map.

pinch-gesture

Use two fingers to zoom, move, or rotate the map.

Map of the exhibition. Map of the First Floor showing the location of 0 exhibitors. Stair to Ground Floor Stair to Ground Floor Großer Saal

Acknowledgements

Not Found

Back to start